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Histomorphometric features of bone in patients with primary Idiopathic adynamic bone disease (ABD), in which
and secondary hypoparathyroidism. serum parathyroid hormone (PTH) concentrations are
Background. Idiopathic adynamic bone disease (ABD) in di- low, has drawn attention in recent years as a type of low-alysis patients is characterized by low serum parathyroid hor-
turnover bone diseases occurring in dialysis patients. Inci-mone (PTH) concentration. Whether ABD itself causes serious
disease is controversial. Fuller understanding of both primary dence of hip and vertebral fractures in patients with ABD
hypoparathyroidism and secondary hypoparathyroidism result- has been reported to exceed that in the general popula-
ing in a long-standing low-PTH state may shed light on proper- tion or in other dialysis patients [1–3]. Reduction of bone
ties of ABD.
mineral density (BMD) in proportion to lowered serumMethods. We performed histomorphometric analysis in bone
PTH concentrations has been postulated as a cause [1].specimens from biopsy in two female patients with primary
hypoparathyroidism and in an autopsy specimen of bone from This bone disease has been noted mainly in elderly indi-
a male patient with secondary hypoparathyroidism related to viduals, diabetic patients, and patients undergoing chronic
long-term hemodialysis; respective ages, 45, 58, and 65 years;
ambulatory peritoneal dialysis (CAPD) [4].dialysis duration, 6 years, 2 months, and 30 years; lumbar bone
However, elderly and diabetic patients may have anmineral density, 2.88, 2.43, and 4.1 SD above the normal mean;
and serum intact PTH, 5, 20, and 84 pg/mL (mean, 30.4). increased risk of falls because of reduced capability for
Tetracycline labeling was performed in the first two cases. daily living and compromised visual acuity; an increase
Results. Histomorphometric analysis in the first two cases in-
in falls could represent a cause of fracture independencedicated a diagnosis of ABD, since no tetracycline labeling could
of osteoporosis.be seen along most of trabecular bone surfaces, total osteoid vol-
ume was decreased, and fibrous tissue was minimal. Bone vol- In the meanwhile, ABD also becomes less likely as a
ume was preserved, and the dense bone-trabecular connectivity cause of reduction of BMD. Niikura et al [5] found no
was noted, with normal lamellar structure. A small number of
difference in BMD between a group of subjects with rela-hump-like structures protruded from the quiescent surface of
tive hypoparathyroidism and otherwise similar subjectstrabecular bone, a pattern which has been called “minimod-
eling.” Tetracycline label was observed in only a small area without hypoparathyroidism.
within trabecular bone in patient 1, and at a region of trabecular Subsequent report concluded that BMD in the femoral
bone surface showing minimodeling in patient 2.
neck and lumbar spine does not decrease even afterThe third case was also diagnosed as ABD; cancellous lamel-
parathyroidectomy [6]. Thus, whether ABD itself causeslar structure and bone volume were normal, although trabecu-
lar connectivity was poor and island bone was relatively promi- fractures and/or reduced BMD is not known.
nent. Minimodeling was evident. Minimodeling bone volume/ Investigation of bone morphology and metabolism in
total bone volume in these three cases was 9.0%, 13.1%, and6.8%,
patients with long-term low PTH concentrations mayrespectively; number of minimodeling sites/total bone volume
help to clarify the pathophysiology of ABD. We describe(N/mm2) was 4.9, 8.6, and 9.0, respectively.
Conclusion. Bone formation mechanism by minimodeling two patients with primary hypoparathyroidism associ-
might contribute to preserving bone volume in dialysis patients ated with short-term hemodialysis and another patient
with hypoparathyroidism, even in the absence of remodeling
with secondary hypoparathyroidism and hemodialysisstimulated by PTH.
duration of 30 years; these serum PTH concentrations
remained low over a long period.Key words: idiopathic adynamic bone disease (ABD), minimodeling, re-
modeling, primary hypoparathyroidism, secondary hypoparathyroidism,
a long-standing low PTH state.
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serum PTH. In May 1990, she manifested renal dysfunc- her renal dysfunction was detected during evaluation of
an upper respiratory infection. The serum creatinine con-tion, as well as hypocalcemia leading to convulsions. The
serum creatinine concentration was 7.3 mg/dL; serum centration was 12.5 mg/dL; serum calcium, 3.1 mEq/L;
phosphate, 5.2 mg/dL; and i-PTH, 19.3 pg/mL. The origi-calcium, 2.7 mEq/L; phosphate, 6.2 mg/dL; and intact
parathyroid hormone (i-PTH), less than 5.0 pg/mL. This nal renal diagnosis in this patient was unclear since no
kidney biopsy had been obtained. However, diabetic ne-patient’s renal diagnosis was unclear since renal biopsy
was not performed. However, Alport syndrome or chronic phropathy was suspected because of proteinuria (2.4
g/day) in the absence of hematuria. The patient wasglomerulonephritis was suspected because of proteinuria
(2 g/day), hematuria(6 to 10 cells per high power field treated with 1 to 2 g of calcium carbonate daily to prevent
hypocalcemia. Although the patient’s renal function(HPF), and sensorineural deafness. The patient was
treated with 0.5 g of vitamin D3 derivatives and 3 g of showed gradual worsening, i-PTH remained less than 20
pg/mL. In September 1999, hemodialysis was beguncalcium carbonate daily to prevent hypocalcemia, and
symptoms remitted. In 1992, hemodialysis three times a three times a week.
On admission, the patient was 148 cm in height andweek was initiated and was continued at an outpatient
clinic. Since initiation of dialysis, serum i-PTH remained her dry weight was 47.5 kg. Her blood pressure was
140/82 mm Hg. She had bilateral diabetic retinopathy.less than 5 pg/mL; serum calcium, 4.5 to 5.0 mEq/L;
serum phosphate, 5.0 to 7.0 mg/dL; and osteocalcin, 10 Serum urea nitrogen was 71 mg/dL; creatinine, 7.6 mg/dL;
alkaline phosphatase, 175 IU/L; calcium, 4.4 mEq/L;to 13 mg/mL. No bone pain and no fractures were noted
during follow-up. phosphate, 6.9 mg/dL; aluminum, 16 and 18 g/L (before
and after deferoxamine at a dose of 5 mg/kg); iron, 41On admission, the patient was 157 cm in height, and
her postdialysis “dry” weight was 54.9 kg. Her blood g/dL; UIBC, 177 g/dL; ferritin, 44 g/L; and magne-
sium, 1.5 mEq/L. Serum PTH was 1.3 pg/mL and osteo-pressure was 110/68 mm Hg. She had bilateral cataracts,
hypertelorism, brachydactyly of the fifth digits, and sen- calcin was 9.9 ng/mL. Computed tomography of the brain
showed small bilateral putaminal calcifications. The pa-sorineural deafness. The serum concentrations of urea
nitrogen were 56 mg/dL; creatinine, 10.0 mg/dL; alkaline tient was diagnosed with primary hypoparathyroidism
in addition to diabetes mellitus because she showed nophosphatase, 98 IU/L; calcium, 5.0 mEq/L; phosphate,
5.6 mg/dL; aluminum, 20 and 25 g/L (before and after any known causes or family history related to primary
hypoparathyroidism.deferoxamine at a dose of 5 mg/kg); iron, 76 g/dL; un-
saturated iron binding capacity (UIBC), 137 g/dL; fer- Bone radiography showed a sclerotic pattern and re-
vealed no fracture lines. BMD of the lumbar spine at L3ritin, 29 g/L; and magnesium, 1.7 mEq/L. The serum
concentration of PTH was less than 5.0 pg/mL and osteo- was 2.43 SD above the normal mean (T score), and BMD
in the unshunted forearm was 1.24 SD over the normalcalcin was 11.6 ng/mL. Computed tomography of the brain
showed small bilateral putaminal calcifications. The pa- mean (T score). BMD has not decreased during a follow-
up period of 5 years (1996 to 2001). Bone pain andtient was diagnosed with primary hypoparathyroidism,
given the absence of other manifestations of endocrinop- fractures have not occurred. On November 4, 1999, right
iliac bone biopsy was performed, 14 days after adminis-athy, acquired causative factors such as surgery, radioio-
dine therapy, or infection, or any family history. tration of tetracycline for double-labeling studies.
Bone radiographs showed a sclerotic pattern and re-
Case 3vealed no fracture lines. The patient’s BMD was mea-
sured by dual-energy x-ray absorptiometry (DEXA). A 65-year-old Japanese man died from asphyxiation
associated with acute bronchitis in March 2001. Hemodi-Lumbar spine (L3) BMD was 2.88 SD above the mean
peak normal bone mass (T score), and BMD in the un- alysis twice a week had been initiated in 1971 because
of chronic renal failure due to gouty nephropathy. Toshunted forearm was 0.93 SD over the corresponding
normal mean (T score). BMD measurements repeated prevent secondary hyperparathyroidism, the patient was
treated continuously with 0.5 to 1.0 g of vitamin D3for 11 years (1990 to 2001) have not changed. On July
28, 1998, a right iliac bone biopsy was performed, 14 days derivatives daily, beginning in 1978. Orally administered
aluminum gels were replaced by 3 to 4 g of calcium car-after administration of tetracycline for triple-labeling
studies. bonate daily given as a phosphate binder beginning in
1987. In 1987, amyloid nodules containing 2-microglob-
Case 2 ulin were resected bilaterally from the ishial tuberosities.
Bilateral carpal tunnel syndrome and destructive spon-A 58-year-old Japanese woman was admitted to our
institution on November 1, 1999, for evaluation of low dyloarthropathy of the cervical spine (C4 to C7) were
diagnosed. No pathologic fractures were noted duringserum PTH. In 1989, when cerebral infarction occurred,
she was diagnosed with diabetes mellitus. Her mother and 30 years of follow-up. Since initiation of dialysis, serum
PTH (measured as the middle fragment and the carboxy-her younger brother were known to have diabetes. In 1996,
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Table 1. Histomorphometric analysis of the bone
Case 1 Case 2 Normal Normal
45 58 40 to 50 female 50 to 60 female
Bone volume (BV/TV) 17.8 38.6 22.85.1% 20.83.1%
Trabecular thickness (Tb.Th) 117.5 166.3 163.634 m 13334 m
Wall thickness (W.Th) 27.7 46.2 44.55.1 30.33.4
Osteoid volume (OV/TV) 0.09 0.24 0.11.0% 0.440.24%
Osteoid volume (OV/BV) 0.5 0.64 4.41.4% 2.171.14%
Osteoid surface (OS/BS) 2.8 5.9 20.47.6% 16.77.0%
Osteoid thickness (O.Th) 11.0 7.1 11.92.4 m 9.22.0 m
Eroded surface (ES/BS) 2.6 14.1 2.50.3% 5.61.9%
Osteoclast number (N.Oc/BS) 0 0.11 mm2
Fibrous tissue volume (Fb.V/TV) 0.0 0.0 0%
Mineral apposition rate (MAR) NC NC 0.520.04 m/day 0.520.04 m/day
Doubly labeled surface (dLS/BS) 0 0 %
Single labeled surface (sLS/BS) 0.9 0 %
Bone formation rate (BFR/BS) NC NC mm3/mm2/year
Bone formation rate (BFR/BV) NC NC %/year
NC is not calculated.
Table 2. Histomorphometric analysis of the boneterminal fragment by radioimmunoassay) remained low
at 2.2 to 4.3 ng/mL and 2.2 to 8.4 ng/mL; since 1990, Case 3 Normal
i-PTH measured by immunoradiometric assay (IRMA) 61 to 70 male
Bone volume (BV/TV) 18.8 14.92.6%showed a low concentration of 30.4  22.5 pg/mL
Trabecular thickness (Tb.Th) 108.8 122.77.3 m(mean  SD; range,12 to 83); Calcium was 4.6  0.3
Wall thickness (W.Th) 29.7 38.75.4
mEq/L and phosphate was 5.5  1.2 mg/dL, during the Osteoid volume (OV/TV) 0.6 0.11.0%
Osteoid volume (OV/BV) 3.2 1.60.4%preceding 11 years.
Osteoid surface (OS/BS) 22.7 23.19.8%On admission, the patient was 165 cm in height and
Osteoid thickness (O.Th) 7.7 9.82.1 m
his dry weight was 47.7 kg. Laboratory results about 1 Eroded surface (ES/BS) 0.7 4.01.2%
Osteoclast number (N.Oc/BS) 0.03 mm2month before autopsy were serum urea nitrogen, 44 mg/dL;
Fibrous tissue volume (Fb.V/TV) 0.03 0%creatinine, 6.6 mg/dL; alkaline phosphatase, 223 IU/L;
Mineral apposition rate (MAR) NC 0.520.04 m/day
calcium, 4.4 mEq/L; phosphate, 6.6 mg/dL; aluminum, Doubly labeled surface (dLS/BS) NC %
Single labeled surface (sLS/BS) NC %10 and 12 g/L (before and after deferoxamine at a dose
Bone formation rate (BFR/BS) NC mm3/mm2/yearof 5 mg/kg); iron, 38 g/dL; UIBC, 198 g/dL; ferritin,
Bone formation rate (BFR/BV) NC %/year
65 g/L; and magnesium, 1.7 mEq/L. Serum i-PTH was
NC is not calculated.44.3 pg/mL and osteocalcin was 10.7 ng/mL. BMD of
the lumbar spine at L3 was 4.1 SD above the normal
mean (T score), and BMD in the unshunted forearm
was 1.8 SD above the normal mean (T score). BMD lar connectivity was evident. Numbers of osteoblasts and
osteoclasts both were decreased, as was the amount ofshowed no decrease during a follow-up period of 6 years
(1994 to 2000). Since the right iliac bone specimen was osteoid. Very little fibrous tissues were present. Polariz-
ing microscopy indicated normal lamellar cancellousobtained at autopsy, tetracycline for double-labeling
analysis had not been administered. bone (Fig. 2 A and B). However, a small number of
hump-like structures protruded from the quiescent sur-
Bone biopsy specimens face of trabecular bone, a pattern which has been called
“minimodeling ” (Fig. 3 A and B). In case 1 and case 2,Undecalcified thin sections 5 mm in thickness prepared
from bone specimens were stained by the Villanueva ratios of minimodeling bone volume to total bone vol-
ume were 9.0% and 13.1%, respectively; ratios of num-methods. Sections were observed with an epifluorescence
microscope, using ultraviolet excitation. With a portion ber of minimodeling sites to total bone volume (N/mm2)
were 4.9 and 8.6, respectively. Fluorescence microscopyof bone trabecula magnified at 160, parameters were
directly measured with an image-analysis system linked did not show labeling by tetracycline at most trabecular
bone surfaces. Focally, tetracycline labeling was ob-to a microcomputer. Histomorphometric findings are in-
dicated in Table 1 (case 1 and case 2) and Table 2 (case 3). served in only a small area within trabecular bone in
case 1 (Fig. 4A) and in a region of minimodeling of theLight microscopic examination showed low normal
bone volume in case 1, and markedly increased bone trabecular bone surface in case 2 (Fig. 4B). No staining
for aluminum was evident. Histomorphometric analysisvolume in case 2, in comparison with age- and gender-
matched controls (Fig. 1 A and B). Dense bone-trabecu- according to previous criteria [7, 8] yielded a diagnosis
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Fig. 2. Polarizing microscopy indicated normal lamellar cancellousFig. 1. Light microscopic examination of the two cases showed normal
bone in case 1 (A) and case 2 (B), and case 3 (C ) showed that mostbone volume in case 1 (A), and markedly increased bone volume in
of the cancellous bone had lamellar structure, while woven bone wascase 2 (B). Light microscopic examination of case 3 (C ) also showed
visible only in small areas. (A), (B), and (C) original magnification40.normal bone volume in comparison with age- and gender-matched con-
trols. However, bone trabecular connectivity was poor, and island bone
was rather prominent. (A) Villanueva staining, original magnification
40; (B) original magnification 40; (C) original magnification 40.
der-matched controls. However, bone trabecular con-
nectivity was poor, and island bone was rather prominent
(Fig. 1C). Polarizing microscopy showed that most ofof aplastic or adynamic bone disease, with decreased
total osteoid volume (15%), essentially no fibrous tis- the cancellous bone had lamellar structure, while woven
bone was visible only in small areas (Fig. 2C). Totalsue volume (0.5%), and a decreased bone formation rate.
Light microscopic examination of case 3 also showed osteoid volume was small (15%), fibrous tissue was
very scant (0.5%), eroded surface was decreased, andnormal bone volume in comparison with age- and gen-
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Fig. 3. A small number of hump-like structures (arrows) protrude from the quiescent surface of trabecular bone, a pattern which has been called
“minimodeling” in case 1 (A) and case 2 (B). Hump-like bone formations (arrows) representing minimodeling sites were evident in case 3 (C, D).
(A) Villanueva staining 100; (B) Villanueva staining 200; (C) Villanueva staining 100; (D) polarizing microscopy 100.
numbers of osteoblasts and osteoclasts both were de- of low-turnover bone disease characterized clinically by
a low serum PTH concentration, and histologically bycreased. Adynamic bone was diagnosed according to
low bone turnover, absence of fibrous tissue, and a nor-previous criteria [7, 8], without measurement of bone
mal amount of osteoid. ABD is distinct from the mildformation rate by tetracycline labeling. No aluminum
type of ROD because of the decreased bone formationstaining was seen. As in case 1 and 2, hump-like bone
rate in ABD. Initially, ABD was reported to be associ-formations representing minimodeling sites were evident
ated with aluminum deposition as well as musculoskele-(Fig. 3 C and D). The ratio of minimodeling bone volume
tal manifestations such as bone pain, proximal myopathy,to total bone volume in this patient was 6.8%; the ratio
and pathologic fractures. After aluminum phosphate-of number of minimodeling sites to total bone volume
binding preparations were replaced by CaCO3 and a(N/mm2) was 9.04.
reverse-osmotic apparatus was adopted for processing
water for dialysate, exposure to aluminum has been mini-
DISCUSSION mized [9–11]. Idiopathic ABD subsequently has emerged
Various bone lesions occurring in patients with chronic as distinct from ABD secondary to aluminum exposure.
renal failure share the general name of “renal osteodys- The idiopathic form has been reported to be more preva-
trophy” (ROD). Osteodystrophy is divided into osteitis lent in patients undergoing CAPD, elderly persons, and
fibrosa (high-turnover bone), osteomalacia (low-turn- diabetic patients [4]. Like aluminum-related ABD, idio-
over bone), a mixed type with features of both osteitis pathic ABD was considered to carry clinical risks; a low
fibrosa and osteomalacia, and a “mild” type. Osteitis fi- PTH concentration could be associated with increased
brosa resulting from excessive PTH and osteomalacia likelihood of fractures, and a plasma i-PTH concentra-
resulting from aluminum deposition have been of major tion of 100 to 300 pg/mL was believed necessary for
normal bone homeostasis in uremic state.clinical importance. ABD represents an additional type
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and 3 years afterward. After parathyroidectomy, BMD
showed a marked increase amounting to 7% to 23% at
all sites. These authors concluded that although PTH
concentrations that had been lowered by parathyroidec-
tomy remained persistently low, BMD did not show a de-
crease. Considering these various studies, whether ABD
itself causes fractures and/or reduced BMD remains con-
troversial.
However, these reports, in which BMD was evaluated
during a limited period of 3 to 6 years, included no truly
long-term study of patients with sustained low PTH.
Because patients with primary hypoparathyroidism have
had low circulating PTH levels for a long time, often
from birth, characterizing the bone lesion in this disease
could shed considerable light on ABD. Several studies
of bone parameters in hypoparathyroidism have shown
greater BMD than in age- and gender-matched controls
[12], but histomorphometric analysis of the bone has not
yet been reported to our knowledge.
According to histomorphometric analysis of bone in
our two patients with primary hypoparathyroidism, can-
cellous trabecular bone showed findings of ABD, includ-
ing a paucity of tetracycline labeling (decreased bone
formation rate), a decrease in both osteoblast and osteo-
clasts, scant osteoid, and no fibrous tissue. However, min-
eralized bone was shown to abundant by both histomor-
phologic analysis and by BMD measurement using DEXA.
Since evidence of the minimodeling phenomenon was
Fig. 4. Fluorescence microscopy did not show labeling by tetracycline present in our two cases and tetracycline labeling oc-
at most trabecular bone surfaces. Focally, tetracycline labeling was ob-
curred in an area with minimodeling, bone formation byserved in only a small area (white arrows) within trabecular bone in case 1
this mechanism might be responsible for preserving bone(A) (magnification 100), and in a region of minimodeling (white
arrows) of the trabecular bone surface in case 2 (B) (magnification200). volume despite hypoparathyroidism and a very slow
bone formation rate.
Next, to elucidate whether this minimodeling mecha-
nism was limited to primary hypoparathyroidism, or alsoAtsumi et al [1] reported that among 187 male hemodi-
would be applicable also to patients with true ABD de-alysis patients, those with serum PTH concentrations in
veloping following induction of dialysis, we performedthe lowest tertile (5 to 60 pg/mL) had a risk of vertebral
bone histomorphometric analysis in an autopsy case (casefracture 2.4 times greater than for the middle tertile (62
3) with hemodialysis duration of 30 years; his serumto 202 pg/mL). Patients with low serum PTH therefore
PTH concentration had remained low over a long period.were considered susceptible to vertebral fracture be-
Although this case was different from the first two incause of decreased lumbar spine BMD. Coco and Rush
that bone trabecular connectivity was poor, island bone[2] found the incidence of hip fracture between 1988
was prominent, and woven bone was visible in only smalland 1998 in 1272 dialysis patients to be increased in
areas; adynamic bone still could be diagnosed accordingindividuals with low serum i-PTH levels (65 pg/mL).
to previous criteria [7, 8]. Bone volume was preserved byMeanwhile, Niikura et al [5] reported that both at
both histomorphologic analysis and BMD measurementinitiation of hemodialysis and 6 years later, BMD mea-
using DEXA. Like cases 1 and 2, hump-like bone forma-sured in the lumbar spine using single-photon absorpti-
tions indicating minimodeling were evident.ometry did not differ between a group with relative hypo-
Formation of cancellous bone may occur accordingparathyroidism and an other group matched for age,
to both remodeling and minimodeling mechanisms. Ingender, and dialysis duration but without any hypopara-
remodeling, bone formation by osteoblasts occurs onlythyroidism. Abdelhadi and Nordenstrom [6] assessed
where bone resorption by osteoclasts has previously oc-BMD overall and in the distal radius, femoral neck, and
curred [13]. Remodeling is regulated systemically bylumbar spine by DEXA in 20 patients treated surgically
PTH, 1,25-dihydroxyvitamin D, and other hormones. Infor hyperparathyroidism associated with hemodialysis.
BMD was measured before parathyroidectomy and 1, 2, minimodeling, bone formation resulting from osteoid
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deposition and successive mineralization occurs at a qui- histologic groups (low-turnover bone, hyperparathyroid-
ism, and mixed osteodystrophy). Although PTH 1-84escent bone surface without prior bone resorption by
osteoclasts. Newly formed bone, therefore, protrudes may be a good index, an accurate interpretation of PTH
7-84 will necessitate further examination.from older bone. In this process, osteoblasts and osteo-
clasts work separately. Linear dividing lines between
newly formed bone and old bone can be observed as
CONCLUSION“lamellar separation.” Minimodeling is reported to be
We performed histomorphometric analysis in boneregulated by dynamic external stress according to Wolff’s
specimens from patients in long-standing low-PTH stateslaw [14–17]. Among patients in an ABD state because
including both primary hypoparathyroidism and second-of low PTH, bone volume of immobilized individuals
ary hypoparathyroidism related to long-term hemodialy-with extremely limited exercise would be lost because
sis. Although ABD was diagnosed in all three patients,minimodeling would not be stimulated. However, bone
bone volume was preserved with normal lamellar struc-volume could be preserved in otherwise similar patients
ture. Minimodeling was present in the all three cases.with exercise sufficient to stimulate minimodeling.
Bone formation by minimodeling may be responsibleAlthough several reports have concluded that idio-
for preservation of bone volume in patients with ABD.pathic ABD does not cause symptoms, other authors re-
In the future, investigation of minimodeling may helpport that the disease is associated with an increased frac-
to clarify bone formation mechanism of various formsture rate [13]. Our study and others suggest that ABD
of ROD, including ABD.patients with high bone volume may be asymptomatic,
but bone pain or bone fractures may be expected in ABD
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